Skip to content

Study of Ajmodadi churna Tablet in Diabetes.

Randomized controlled trial of ââ?¬Å? Ajmodadi churna vatiââ?¬? as an add-on effect in the management of Madhumeha.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020023
Enrollment
60
Registered
2019-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Oral Hypoglycemic Drug: continue conventional OHA as per prescribed dose Control Intervention1: Ajmodadi churna vati: 500 mg twice a day orally with luke warm water for 3 months

Sponsors

Sumatibhai Shah Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. A known Diabetic on treatment and a newly diagnosed Diabetes. 2. Patient with fasting blood sugar up to 220 mg% and post prandial blood sugar up to 300 mg%. 3. Patient having HbA1C upto 10. 4. If the patient is taking ayurvedic medicine for Madhumeha, Washout period for them will be 8 days.

Exclusion criteria

Exclusion criteria: 1. Patients with fasting blood sugar above 220 mg% and post prandial blood sugar above 300mg%. 2. Patient who is already taking Ayurvedic management for Madhumeha. 3. Diabetes Mellitus Type-I ,Acromegaly, Cushingââ?¬•s syndrome and pancreatic disorder. 4. Those who are under Insulin therapy. 5. Pregnant and lactating mothers. 6. Patients with acute complications like Hyperglycemic coma, Ketoacidosis and infections like gangrene. 7. Patients with K/C/O Nephropathy, Neuropathy and Retinopathy. 8. Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV)

Design outcomes

Primary

MeasureTime frame
1)Blood sugar level Fasting and Post prandial 2) HbA1cTimepoint: 3 months

Secondary

MeasureTime frame
1)Blood Sugar(fasting and PP) 2) HbA1c levels. Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Karishma Kadam

MUHS Nashik

karishmakadam722@gmail.com7057574450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026